indirubin has been researched along with Bowel Diseases, Inflammatory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Z; Li, S; Li, Y; Peng, H; Pu, W; Wei, F; Zhang, T; Zhang, Y; Zhou, Q; Zhou, X | 1 |
| Du, Z; Pu, W; Tao, Z; Wei, F; Wu, J; Yang, Y; Zhang, L; Zhang, Y; Zhou, Q; Zhou, X | 1 |
2 other study(ies) available for indirubin and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Indirubin regulates T cell differentiation by promoting αVβ8 expression in bone marrow-derived dendritic cells to alleviate inflammatory bowel disease.
Topics: Animals; Bone Marrow; Cell Differentiation; Cells, Cultured; Cytokines; Dendritic Cells; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; RNA, Small Interfering; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2023 |
Xi Lei San Attenuates Dextran Sulfate Sodium-Induced Colitis in Rats and TNF-
Topics: Animals; Autophagy; Caco-2 Cells; Cytokines; Dextran Sulfate; Female; Humans; Indoles; Inflammasomes; Inflammatory Bowel Diseases; Medicine, Chinese Traditional; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2021 |